×
EGFR mutation specific immunohistochemistry revolutionises time to treatment with tyrosine kinase inhibitors (TKIs)
Sinharay R., Mithra S., Patel P., Ah-Moye A., Morrow S., Khiroya R., Falzon M., Borg E., Ahmed T., Forster M., Navani N.
DOI
10.1016/S0169-5002(18)30085-0
Type
Journal article
Publication Date
2018-01-01T00:00:00+00:00
Volume
115
Pages
S24 - S24